Rapid isolation and susceptibility testing of Leptospira spp. Using a new solid medium, LVW agar

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 297-302

  Wuthiekanun, Vanaporn ^a   Amornchai, Premjit ^a   Paris, Daniel H ^a,b   Langla, Sayan ^a   Thaipadunpanit, Janjira ^a   Chierakul, Wirongrong ^a   Smythe, Lee D ^c   White, Nicholas J ^a,b   Day, Nicholas P J ^a,b   Limmathurotsakul, Direk ^a   Peacocka, Sharon J ^a,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEENSLAND HEALTH   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; DOXYCYCLINE; PENICILLIN G; RABBIT ANTISERUM;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; EPSILOMETER TEST; INCUBATION TIME; LEPTOSPIRA; LEPTOSPIRA BORGPETERSENII; LEPTOSPIRA INTERROGANS; LEPTOSPIRA KIRSCHNERRI; MICROBIAL SENSITIVITY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AGAR; ANIMALS; ANTI-BACTERIAL AGENTS; CARBON DIOXIDE; COLONY COUNT, MICROBIAL; CULTURE MEDIA; HUMANS; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MICROBIAL SENSITIVITY TESTS; RABBITS;

EID: 84872046816     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01812-12     Document Type: Article

References (33)

1. Ko AI, Goarant C, Picardeau M. 2009. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol. 7:736 -747.
2. Levett, PN 2001. Leptospirosis. Clin. Microbiol. Rev. 14:296 -326.
3. Adler B, de la Pena Moctezuma A. 2010. Leptospira and leptospirosis. Vet. Microbiol. 140:287-296.
4. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM. 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3:757-771.
5. Suttinont C, Losuwanaluk K, Niwatayakul K, Hoontrakul S, Intaranongpai W, Silpasakorn S, Suwancharoen D, Panlar P, Saisongkorh W, Rolain JM, Raoult D, Suputtamongkol Y. 2006. Causes of acute, undifferentiated, febrile illness in rural Thailand: results of a prospective observational study. Ann. Trop. Med. Parasitol. 100:363-370.
6. Wuthiekanun V, Chierakul W, Limmathurotsakul D, Smythe LD, Symonds ML, Dohnt MF, Slack AT, Limpaiboon R, Suputtamongkol Y, White NJ, Day NP, Peacock SJ. 2007. Optimization of culture of Leptospira from humans with leptospirosis. J. Clin. Microbiol. 45:1363-1365.
7. Suputtamongkol Y, Niwattayakul K, Suttinont C, Losuwanaluk K, Limpaiboon R, Chierakul W, Wuthiekanun V, Triengrim S, Chenchittikul M, White NJ. 2004. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin. Infect. Dis. 39:1417-1424.
8. Harris BM, Blatz PJ, Hinkle MK, McCall S, Beckius ML, Mende K, Robertson JL, Griffith ME, Murray CK, Hospenthal DR. 2011. In vitro and in vivo activity of first generation cephalosporins against Leptospira. Am. J. Trop. Med. Hyg. 85:905-908.
9. Hospenthal DR, Murray CK. 2003. In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrob. Agents Chemother. 47:2646 -2648.
10. Kim D, Kordick D, Divers T, Chang YF. 2006. In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin. J. Vet. Sci. 7:355-359.
11. Murgia R, Cinco M. 2001. Sensitivity of Borrelia and Leptospira to quinupristin- dalfopristin (Synercid) in vitro. New Microbiol. 24:193-196.
12. Murray CK, Ellis MW, Hospenthal DR. 2004. Susceptibility of Leptospira serovars to antimalarial agents. Am. J. Trop. Med. Hyg. 71:685- 686.
13. Murray CK, Hospenthal DR. 2004. Broth microdilution susceptibility testing for Leptospira spp. Antimicrob. Agents Chemother. 48:1548 -1552.
14. Murray CK, Hospenthal DR. 2004. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob. Agents Chemother. 48:4002- 4005.
15. Oie S, Hironaga K, Koshiro A, Konishi H, Yoshii Z. 1983. In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents. Antimicrob. Agents Chemother. 24:905-908.
16. Ressner RA, Griffith ME, Beckius ML, Pimentel G, Miller RS, Mende K, Fraser SL, Galloway RL, Hospenthal DR, Murray CK. 2008. Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. Antimicrob. Agents Chemother. 52:2750 -2754.
17. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. 2003. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin. Infect. Dis. 36:1507-1513.
18. Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP, Laughlin LW. 1988. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet i:433- 435.
19. Johnson RC, Walby J, Henry RA, Auran NE. 1973. Cultivation of parasitic leptospires: effect of pyruvate. Appl. Microbiol. 26:118 -119.
20. Smythe LD. 2012. EMJH agar. Quality Information Systems Document number 14340, vol 3.0. WHO/FAO/OIE Collaborating Center for Reference and Research on Leptospirosis, Queensland Health Forensic and Scientific Services, Queensland Health, Queensland, Australia.
21. Bromley DB, Charon NW. 1979. Axial filament involvement in the motility of Leptospira interrogans. J. Bacteriol. 137:1406 -1412.
22. Orr HS, Little TW. 1979. Isolation of Leptospira of the serotype hardjo from bovine kidneys. Res. Vet. Sci. 27:343-346.
23. Freitas JC, Silva FG, Oliveira RC, Delbem ACB, Muller EE, Alves LA, Teles PS. 2004. Isolation of Leptospira spp from dogs, bovine and swine naturally infected. Cien. Rur. Santa Maria 34:853- 856.
24. Faine S, Adler B, Bolin C, Perolat P. 1999. Leptospira and leptospirosis. MediSci, Melbourne, Australia.
25. Yanagawa R, Hiramune T, Fujita J. 1963. Effect of carbon dioxide on the colonial growth of pathogenic leptospirae. J. Bacteriol. 85:875- 878.
26. Thaipadungpanit J, Wuthiekanun V, Chierakul W, Smythe LD, Petkanchanapong W, Limpaiboon R, Apiwatanaporn A, Slack AT, Suputtamongkol Y, White NJ, Feil EJ, Day NP, Peacock SJ. 2007. A dominant clone of Leptospira interrogans associated with an outbreak of human leptospirosis in Thailand. PLoS Negl. Trop. Dis. 1 :e56. doi:10.1371/ journal.pntd.0000056.
27. Bursac Z, Gauss CH, Williams DK, Hosmer DW. 2008. Purposeful selection of variables in logistic regression. Source Code Biol. Med. 3:17. doi:10.1186/1751-0473-3-17.
28. Stalheim OH, Wilson JB. 1963. Leptospiral colonial morphology. J. Bacteriol. 86:482- 489.
29. Wood J, Johnson RC, Palin K. 1981. Surface colonies of Leptospira interrogans. J. Clin. Microbiol. 13:102-105.
30. Cox CD, Larson AD. 1957. Colonial growth of leptospirae. J. Bacteriol. 73:587-589.
31. Rule PL, Alexander AD. 1986. Gellan gum as a substitute for agar in leptospiral media. J. Clin. Microbiol. 23:500 -504.
32. Johnson RC, Gary ND. 1962. Nutrition of Leptospira pomona. 1. A chemically defined substitute for rabbit serum ultrafiltrate. J. Bacteriol. 83:668-672.
33. Limmathurotsakul D, Turner EL, Wuthiekanun V, Thaipadungpanit J, Suputtamongkol Y, Chierakul W, Smythe LD, Day NP, Cooper B, Peacock SJ. 2012. Fool's gold: why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis. Clin. Infect. Dis. 55:322-331.